Resistance to a commonly used antimalarial medication, Atovaquone, can’t spread to the general human population, a new research found.
- Co-head, Gilson/Crabb Laboratory & Senior Research Officer, Burnet Institute
A new drug for malaria could be developed after a way has been found to kill the parasite that causes the disease. Malaria remains one of the world’s top three single-cause infectious diseases and is caused…
Contact Paul for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Melbourne, Australia
- Website
- Article Feed
- Joined
